Company: SCLXW
Filing Date: 2025-05-14
Form Type: 424B3
Source: 0001193125-25-119846
Chunk: 409

Company: Scilex Holding Co
Filing Date: 2025-05-14
Form: 424B3
Chunk 409
---
 such exercise and the Company shall, upon such exercise, round up to the nearest whole number of shares of Common Stock to be issued to such holder). Accordingly, the Private Warrants held by SCLX 
 JV are currently exercisable for 14,018 shares of Common Stock. The voting and dispositive power of the equity securities of the Company (including the Series A Preferred Stock) held by SCLX JV are subject to the control of an independent manager,  
 Xiao Xu, until such time as the Oramed Note and any Additional Notes are paid in full. The business address of SCLX Stock Acquisition JV LLC is 960 San Antonio Road, Palo Alto, CA 94303.                                                               |

| (10) | Represents 350,000 shares of Common Stock held directly and 382,717 shares underlying certain warrants to                                                                                                                                      
 purchase Common Stock, with an exercise price of $0.01 per share, held by Oramed exercisable within 60 days of March 31, 2025. Such warrants held by Oramed are subject to a 9.99% beneficial ownership limitation and the number of shares of 
 Common Stock set forth in the table above give effect to such limitation. The foregoing ownership information for Oramed is based on information supplied by Oramed in a statement on Schedule 13G filed with the SEC on January 17, 2025 that 
 reports its sole voting power and sole dispositive power and a Form 4 filed with the SEC by SCLX JV on January 23, 2025. The business address of Oramed Pharmaceuticals Inc. is 1185 Avenue of the Americas, Third Floor, New York, NY 10036.  |

257

SELLING SECURITYHOLDERS

This prospectus relates to the offer and sale from time to time by:

(a) the Selling Stockholders of up to an aggregate of 1,594,207 Resale Shares, consisting of: (i) up to 41,082 Sponsor Shares;
(ii) up to 1,513,040 Merger Shares, of which 1,458,263 are held by SCLX JV; and (iii) up to 40,085 Private Warrant Shares issuable pursuant to Private Warrants; and

(b) the Selling Warrantholders, of up to 1,402,955 Private Warrants. In connection with the Reverse Stock Split, the SPAC Warrants (which
include the Private Warrants) were